Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 24, 2015 12:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics to Present at the LD Micro Main Event

TORONTO, Nov. 24, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
October 27, 2015 06:15 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics to Present at The MicroCap Conference

TORONTO, Oct. 27, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
October 09, 2015 07:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics to Present at Dawson James Securities Growth Stock Conference

TORONTO, Oct. 9, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
October 09, 2015 07:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces Third Quarter 2015 Results

TORONTO, Oct. 9, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
August 05, 2015 08:15 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Updates Status of Tentative Approvals of Generic Focalin XR(R)

TORONTO, Aug. 5, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
July 13, 2015 07:30 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces Second Quarter 2015 Results

TORONTO, July 13, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
July 08, 2015 18:20 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Updates Status of Tentative Approvals of Generic Focalin XR(R)

TORONTO, July 8, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
June 18, 2015 17:30 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Updates Status of Tentative Approvals of Generic Focalin XR(R)

TORONTO, June 18, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
May 26, 2015 08:00 ET | Source: Intellipharmaceutics International Inc.

FDA Grants Fast Track Designation for Intellipharmaceutics Rexista(TM) Oxycodone XR Incorporating PODRAS(TM) Technology

TORONTO, May 26, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...
May 25, 2015 20:50 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces Agreement to Acquire Real Property that Houses its Manufacturing, R&D and Office Facilities in Toronto, Ontario and Status of 5mg Strength of its Generic Focalin XR(R)

TORONTO, May 25, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the...